UnitedHealth Group Inc. (NYSE:UNH) has been given a consensus rating of “Buy” by the twenty-six brokerages that are currently covering the company. One investment analyst has rated the stock with a hold rating, twenty-three have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $154.61.

UNH has been the subject of a number of recent research reports. Wedbush reissued an “outperform” rating and set a $165.00 price objective on shares of UnitedHealth Group in a report on Tuesday, July 19th. Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price objective for the company in a report on Friday, July 22nd. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, June 21st. Citigroup Inc. boosted their price objective on UnitedHealth Group from $148.00 to $164.00 and gave the stock a “buy” rating in a report on Wednesday, July 20th. Finally, Credit Suisse Group AG reissued a “buy” rating and set a $148.00 price objective on shares of UnitedHealth Group in a report on Wednesday, June 29th.

In related news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.65% of the stock is owned by corporate insiders.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/unitedhealth-group-inc-nyseunh-given-average-rating-of-buy-by-analysts.html

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in UNH. Van Hulzen Asset Management LLC bought a new position in shares of UnitedHealth Group during the second quarter worth about $104,000. Archford Capital Strategies LLC boosted its position in shares of UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 696 shares during the period. MCF Advisors LLC boosted its position in shares of UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock worth $123,000 after buying an additional 726 shares during the period. Hanson McClain Inc. boosted its position in shares of UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $126,000 after buying an additional 4 shares during the period. Finally, Howe & Rusling Inc. boosted its position in shares of UnitedHealth Group by 4.5% in the second quarter. Howe & Rusling Inc. now owns 920 shares of the healthcare conglomerate’s stock worth $130,000 after buying an additional 40 shares during the period. 85.78% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group (NYSE:UNH) traded up 0.56% during mid-day trading on Wednesday, reaching $138.24. The company had a trading volume of 1,530,723 shares. UnitedHealth Group has a one year low of $107.51 and a one year high of $144.48. The company’s 50-day moving average is $139.00 and its 200-day moving average is $135.11. The stock has a market capitalization of $131.66 billion, a PE ratio of 21.63 and a beta of 0.57.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.07. The firm earned $46.50 billion during the quarter, compared to analyst estimates of $45.05 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. Equities research analysts anticipate that UnitedHealth Group will post $7.92 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were paid a $0.625 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 dividend on an annualized basis and a yield of 1.82%. UnitedHealth Group’s dividend payout ratio is presently 39.12%.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.